Preparation and characterization of coenzyme Q10-loaded PMMA nanoparticles by a new emulsification process based on microfluidization

被引:53
作者
Kwon, SS [1 ]
Nam, YS [1 ]
Lee, JS [1 ]
Ku, BS [1 ]
Han, SH [1 ]
Lee, JY [1 ]
Chang, IS [1 ]
机构
[1] Amore Pacific R&D Ctr, Nanotechnol Res Team, Yongin Si 449729, Gyounggi Do, South Korea
关键词
coenzyme Q(10); nanoparticles; microfluidization; poly(methyl methacrylate); drug stability;
D O I
10.1016/S0927-7757(02)00212-1
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A microfluidization and solvent evaporation method was employed to prepare poly(methyl methacrylate) (PMMA) nanoparticles containing coenzyme Q(10). Dynamic light scattering and transmission electron microscopy showed that the mean diameter of the nanoparticles was highly influenced by the kind of surfactants used and the recycling number of the microfluidization process. Particles with sizes from 40 to 260 nm and low polydispersities were produced with good reproducibility. Despite a very high target drug loading yield, 38.7% (w/w), the actual loading efficiency reached above 95%, as demonstrated by H-1 NMR analysis. Coenzyme Q(10) formed a crystal structure within the polymer matrix with a melting temperature of 48 degreesC, as demonstrated by differential scanning calorimetry. No free drug crystals were found in the aqueous suspension of nanoparticles. A comparative study on structural stability of coenzyme Q(10) showed that both UV and high temperature-induced drug inactivation were effectively hindered when the drug was encapsulated within the polymer nanoparticles. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 18 条
[1]  
BODMEIER R, 1993, DRUG DEV IND PHARM, V19, P521
[2]   INDOMETHACIN POLYMERIC NANOSUSPENSIONS PREPARED BY MICROFLUIDIZATION [J].
BODMEIER, R ;
CHEN, HG .
JOURNAL OF CONTROLLED RELEASE, 1990, 12 (03) :223-233
[3]   POLYALKYLCYANOACRYLATE NANOPARTICLES AS DRUG CARRIER - PRESENT STATE AND PERSPECTIVES [J].
COUVREUR, P ;
VAUTHIER, C .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) :187-198
[4]   Poly(epsilon-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity [J].
Espuelas, MS ;
Legrand, P ;
Irache, JM ;
Gamazo, C ;
Orecchioni, AM ;
Devissaguet, JP ;
Ygartua, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 158 (01) :19-27
[5]  
Folkers K., 1986, BIOMEDICAL CLIN ASPE, V5, P375
[6]   Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF) [J].
Gibaud, S ;
Rousseau, C ;
Weingarten, C ;
Favier, R ;
Douay, L ;
Andreux, JP ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :131-139
[7]   COENZYME-Q10 - A NEW DRUG FOR CARDIOVASCULAR-DISEASE [J].
GREENBERG, S ;
FRISHMAN, WH .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (07) :596-608
[8]   Particle design using supercritical fluids: Literature and patent survey [J].
Jung, J ;
Perrut, M .
JOURNAL OF SUPERCRITICAL FLUIDS, 2001, 20 (03) :179-219
[9]   Effect of oral coenzyme Q10 supplementation on the oxidation resistance of human VLDL+LDL fraction: Absorption and antioxidative properties of oil and granule-based preparations [J].
Kaikkonen, J ;
Nyyssonen, K ;
PorkkalaSarataho, E ;
Poulsen, HE ;
MetsaKetela, T ;
Hayn, M ;
Salonen, R ;
Salonen, JT .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (07) :1195-1202
[10]  
Kommuru TR, 1999, CHEM PHARM BULL, V47, P1024